Summary
“American Pie” actress Jasmine Mooney, a Canadian citizen, was detained by ICE while attempting to renew her work visa at the U.S.-Mexico border on March 3.
She described the experience as a “deeply disturbing psychological experiment,” including sleeping on a mat with “aluminum foil wrapped over my body like a dead body,” being transported in chains, and receiving inedible food.
Officials allegedly told her she was “unprofessional because I didn’t have a proper letterhead” on her paperwork.
After her release, Mooney credited media attention and her support network for securing her freedom.
While the actress has some notoriety, huge part of the international trade relies on short term work visa. When Airbus builds a new factory in the US, or That a US factory chooses German industrial robots, you need to send people on short-term work visa to kickstart it.
And there are numerous European/German companies who have already have put a hold on all US travel for their staff. Some critical infrastructure/defence companies even seek to implement “not even for vacation” clauses for their management levels.
The German government is openly considering a travel warning. Which would fuck over things a lot because then a) employers can hardly make their staff go to the US anymore b) most travel insurance companies won’t cover the US anymore with their standard plans (it’s already more expensive due to the insane healthcare costs) and require individual high risk country plans - which are a lot of paperwork and everything.
This will fuck over the US royally - because even if Trump wants to push US based manufacturing these factories need equipment. And this equipment is really not produced in the US much - it comes from Europe/Japan if you want the best and China if you are interested in the “cheap” stuff. But now it will come with either a hefty surcharge (think like double the price - or more) or not come at all because it’s not worth the hazzle.
Especially for factory equipment, healthcare (there are already a lot of medical product manufacturers who simply do not serve the US market due to the insane costs to access it with little to gain) and pharma this is very relevant.